https://orcid.org/0000-0002-2370-4823
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kiyoshi Kubota & Nobuhiro Ooba. (2022) Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population. Clinical Epidemiology 14, pages 623-639.
Read now
Read now
Articles from other publishers (20)
Ling Zhang, Yasuhisa Ono, Qing Qiao & Toshiyuki Nagai. (2023) Trends in heart failure prevalence in Japan 2014–2019: a report from healthcare administration databases. ESC Heart Failure 10:3, pages 1996-2009.
Crossref
Crossref
Hayato Yamana, Takaaki Konishi & Hideo Yasunaga. (2023)
Validation studies of
J
apanese administrative health care data: A scoping review
. Pharmacoepidemiology and Drug Safety.
Crossref
Crossref
Thomas Laurent, Dimitra Lambrelli, Ryozo Wakabayashi, Takahiro Hirano & Ryohei Kuwatsuru. (2023) Strategies to Address Current Challenges in Real-World Evidence Generation in Japan. Drugs - Real World Outcomes.
Crossref
Crossref
Nobuhiro Narii, Tetsuhisa Kitamura, Sho Komukai, Ling Zha, Masayo Komatsu, Fumiko Murata, Megumi Maeda, Kosuke Kiyohara, Tomotaka Sobue & Haruhisa Fukuda. (2023) Association of pneumococcal vaccination with cardiovascular diseases in older adults: The vaccine effectiveness, networking, and universal safety (VENUS) study. Vaccine 41:13, pages 2307-2313.
Crossref
Crossref
Chelsie Hurst, Maira Soto, Ernest R. Vina & Kathleen E. Rodgers. (2023) Renin-Angiotensin System-Modifying Antihypertensive Drugs Can Reduce the Risk of Cardiovascular Complications in Lupus: A Retrospective Cohort Study. The American Journal of Medicine 136:3, pages 284-293.e4.
Crossref
Crossref
Yuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, Akira Okada, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Koichi Node, Hideo Yasunaga & Issei Komuro. (2022) Reduction in blood pressure for people with isolated diastolic hypertension and cardiovascular outcomes. European Journal of Preventive Cardiology.
Crossref
Crossref
Shusuke Watanabe, Jung-ho Shin, Tetsuji Morishita, Daisuke Takada, Susumu Kunisawa & Yuichi Imanaka. (2022) Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan. Journal of Atherosclerosis and Thrombosis 29:11, pages 1571-1587.
Crossref
Crossref
Yaa‐Hui Dong, Chia‐Hsuin Chang, Jou‐Wei Lin, Wei‐Shun Yang, Li‐Chiu Wu & Sengwee Toh. (2022) Comparative cardiovascular effectiveness of glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter‐2 inhibitors in patients with type 2 diabetes: A population‐based cohort study. Diabetes, Obesity and Metabolism 24:8, pages 1623-1637.
Crossref
Crossref
Takashi Fujiwara, Takashi Kanemitsu, Kosei Tajima, Akinori Yuri, Masahiro Iwasaku, Yasuyuki Okumura & Hironobu Tokumasu. (2022) Accuracy of algorithms to identify patients with a diagnosis of major cancers and cancer-related adverse events in an administrative database: a validation study in an acute care hospital in Japan. BMJ Open 12:7, pages e055459.
Crossref
Crossref
Atsushi NishikawaEiko YoshinagaMasaki NakamuraMasayoshi SuzukiKeiji KidoNaoto TsujimotoTaeko IshiiDaisuke Koide. (2022) Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare Database. Annals of Clinical Epidemiology 4:1, pages 20-31.
Crossref
Crossref
Mohamed O. Mohamed, Harriette G.C. Van Spall, Carlos Morillo, Steve B. Wilton, Evangelos Kontopantelis, Muhammad Rashid, Pensee Wu, Ashish Patwala & Mamas A. Mamas. (2022) The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States. Mayo Clinic Proceedings 97:1, pages 88-100.
Crossref
Crossref
Azusa Hara, Takumi Hirata, Tomonori Okamura, Shinya Kimura & Hisashi Urushihara. (2021) Lifestyle behaviors associated with the initiation of renal replacement therapy in Japanese patients with chronic kidney disease: a retrospective cohort study using a claims database linked with specific health checkup results. Environmental Health and Preventive Medicine 26:1.
Crossref
Crossref
Cynthia Luise, Naonobu Sugiyama, Toshitaka Morishima, Takakazu Higuchi, Kayoko Katayama, Sho Nakamura, Haoqian Chen, Edward Nonnenmacher, Ryota Hase, Sadao Jinno, Mitsuyo Kinjo, Daisuke Suzuki, Yoshiya Tanaka & Soko Setoguchi. (2021) Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study. Pharmacoepidemiology and Drug Safety 30:9, pages 1153-1161.
Crossref
Crossref
Hiroyuki Ohbe & Hideo Yasunaga. (2021) Spouse’s Cardiovascular Disease As a Risk Factor for Cardiovascular Disease in Middle-Aged Adults: A Matched-Pair Cohort Study. Circulation: Cardiovascular Quality and Outcomes 14:8.
Crossref
Crossref
Mohamed O. Mohamed, Tahmeed Contractor, Dmitry Abramov, Purvi Parwani, Erin D. Michos, David Fischman, M Chadi Alraies, Rodrigo Bagur & Mamas A. Mamas. (2021) Sex-Based Differences in Prevalence and Outcomes of Common Acute Conditions Associated With Type 2 Myocardial Infarction. The American Journal of Cardiology 147, pages 8-15.
Crossref
Crossref
Atsushi Mizuno, Mitsunori Miyashita, Sachiko Ohde, Osamu Takahashi, Sayoko Yamauchi, Hitonari Nakazawa & Nobuyuki Komiyama. (2021) Differences in aggressive treatments during the actively dying phase in patients with cancer and heart disease: an exploratory study using the sampling dataset of the National Database of Health Insurance Claims. Heart and Vessels 36:5, pages 724-730.
Crossref
Crossref
Kazuya Fujihara, Mayuko Yamada‐Harada, Yasuhiro Matsubayashi, Masaru Kitazawa, Masahiko Yamamoto, Yuta Yaguchi, Hiroyasu Seida, Satoru Kodama, Kohei Akazawa & Hirohito Sone. (2021)
Accuracy of Japanese claims data in identifying
diabetes‐related
complications
. Pharmacoepidemiology and Drug Safety 30:5, pages 594-601.
Crossref
Crossref
Chia-Ter Chao, Szu-Ying Lee, Jui Wang, Kuo-Liong Chien & Kuan-Yu Hung. (2021) The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis. Cardiovascular Diabetology 20:1.
Crossref
Crossref
Bo Kyung Koo, SangHyun ParkKyung-Do HanMin Kyong Moon. (2021) Hypertriglyceridemia Is an Independent Risk Factor for Cardiovascular Diseases in Korean Adults Aged 30–49 Years: a Nationwide Population-Based Study. Journal of Lipid and Atherosclerosis 10:1, pages 88.
Crossref
Crossref
Yutaka Seino, Dae Jung Kim, Daisuke Yabe, Elise Chia‐Hui Tan, Wook‐Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Moe H. Kyaw, Anouk Deruaz‐Luyet, Kimberly G. Brodovicz & Wayne H.‐H. Sheu. (2020) Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study. Endocrinology, Diabetes & Metabolism 4:1.
Crossref
Crossref